Immunological Aspects of Malignant Gliomas. - Wikidata - wikimedia - TriplyDB

Immunological Aspects of Malignant Gliomas.

Immunological Aspects of Malignant Gliomas.

http://www.wikidata.org/entity/Q38870994

about

Expression and prognostic impact of matrix metalloproteinase-2 (MMP-2) in astrocytomas.

P2860

Q36289595-21001AB3-CA22-42D8-8D07-90B0F57EDD99

P2860

Immunological Aspects of Malignant Gliomas.

http://www.wikidata.org/entity/Q38870994

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Immunological Aspects of Malignant Gliomas.

@en

type

label

Immunological Aspects of Malignant Gliomas.

@en

prefLabel

Immunological Aspects of Malignant Gliomas.

@en

P1433

Q38870994-D1EE03BC-BB96-44FA-8510-7749D5D8C754

P1476

Q38870994-3C837696-21AB-4E3B-90DF-D23C756F2B7B

P2093

Q38870994-59F27631-D0CC-438C-B7BC-4C000F54B0E1

P2860

Q38870994-0D87E539-7F4A-49C4-8D6D-9C0EF4834F72

Q38870994-0DB7C4C3-E07E-4F57-AC99-8B348585C76F

Q38870994-0E57F8AC-F554-43D6-BB31-5BBB8842CEDA

Q38870994-196E1ED5-B42B-4B6E-B8F3-5B4C86C79748

Q38870994-1E21C2BD-BA48-4244-AAA9-9141C517E25B

Q38870994-255F7C55-17AF-414D-8A6B-C9A366D5D0AF

Q38870994-28BFD4DA-3CE5-4582-A37C-8BEA4C27B5F8

Q38870994-32733EB2-F959-434B-8021-84C9A3F165FE

Q38870994-33DDEAC9-D521-4A5B-A980-EE4DE2931BB7

Q38870994-343EA677-2675-48BD-8517-B7B10855456C

P304

Q38870994-7476FBA2-BD00-4B4F-8AE4-A4F3AC79428B

P31

Q38870994-6C69644D-7161-4390-AD26-942081E56139

P356

Q38870994-6C806819-CE27-4AA6-82A5-1EA21D63EAC8

P433

Q38870994-143D1A64-AC78-4362-91A4-3A634A7B5A51

P478

Q38870994-45DF5CF9-68BC-4ECA-B567-43F747C9F3B8

P50

Q38870994-E0D739F8-9DFB-41B7-8A7E-ED100CF2A516

P577

Q38870994-2EDE4FCC-F9A0-439F-AB8C-216A299DAD8C

P5875

Q38870994-7189F69A-17D4-4192-B8C7-4DB191F83318

P698

Q38870994-59248886-A003-4C57-A02C-91D4DCE26DCD

P921

Q38870994-0C48AC3F-A135-4F1E-A505-1DD9BF9FA4E4

P356

P1433

Canadian Journal of Neurological Sciences

P1476

Immunological Aspects of Malignant Gliomas.

@en

P2093

Menashe Zaaroor

http://www.w3.org/2001/XMLSchema#string

P2860

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

Ipilimumab: an anti-CTLA-4 antibody for metastatic melanoma

Nivolumab plus ipilimumab in advanced melanoma.

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Concepts of immunotherapy for glioma

Heat shock protein vaccines against glioblastoma: from bench to bedside

Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma

PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma

Direct phenotypic analysis of human MHC class I antigen presentation: visualization, quantitation, and in situ detection of human viral epitopes using peptide-specific, MHC-restricted human recombinant antibodies.

Modification of a tumor-derived peptide at an HLA-A2 anchor residue can alter the conformation of the MHC-peptide complex: probing with TCR-like recombinant antibodies.

P304

494-502

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1017/CJN.2016.34

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

43

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

293488890

http://www.w3.org/2001/XMLSchema#string

P698

27324313

http://www.w3.org/2001/XMLSchema#string

P921